Roche Holding AG Share Price London S.E.
Stocks
0QOK
CH0012032048
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 28/07 | Sika raises annual sales-growth outlook after strong first-half performance | RE |
| 27/07 | IDEAYA Biosciences Advances IDE892 Into Phase 1/2 Monotherapy Expansion | MT |
| Market Cap | 29TCr 36TCr 31TCr 27TCr 50TCr 34,30300Cr 52TCr 3,48300Cr 1,36200Cr 16,97500Cr 1,34500Cr 1,31500Cr 58,68100Cr | P/E 2026 * |
20.4x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 30TCr 37TCr 33TCr 28TCr 52TCr 35,55800Cr 54TCr 3,61100Cr 1,41200Cr 17,59500Cr 1,39400Cr 1,36400Cr 60,82700Cr | EV / Sales 2026 * |
4.86x | EV / Sales 2027 * | 4.55x |
| Free-Float |
88.78% | Yield 2026 * |
2.72% | Yield 2027 * | 2.78% |
Last Transcript: Roche Holding AG
| 1 day | +12.16% | ||
| Current month | +0.48% | ||
| 6 months | -5.69% | ||
| Current year | -1.29% |
| Current year | 311.6 |  | 377 |
| 1 year | 221.3 | | 377 |
| 3 years | 212.3 | | 377 |
| 5 years | 212.3 | | 404.1 |
| 10 years | 202.23 | | 404.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
| Chief Operating Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 36TCr | |
| -0.19% | +4.72% | +59.64% | +167.95% | 1,08900Cr | |
| +0.19% | +4.51% | +58.93% | +59.48% | 64TCr | |
| +1.20% | +5.21% | +39.37% | +78.17% | 47TCr | |
| -0.51% | +3.51% | +36.97% | +42.46% | 30TCr | |
| +1.50% | +3.40% | +17.71% | +17.41% | 27TCr | |
| +0.79% | +5.81% | -2.55% | -38.10% | 23TCr | |
| -0.71% | +6.60% | +28.55% | +66.65% | 21TCr | |
| -0.15% | +2.98% | +17.50% | +76.28% | 17TCr | |
| -0.18% | +1.51% | +3.68% | -30.13% | 14TCr | |
| Average | +1.36% | +3.90% | +28.87% | +48.91% | 39.06TCr | |
| Weighted average by Cap. | +1.26% | +4.40% | +41.52% | +82.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.26TCr 7.64TCr 6.71TCr 5.75TCr 11TCr 7,31600Cr 11TCr 74TCr 29TCr 3,62000Cr 29TCr 28TCr 12,51500Cr | 6.55TCr 7.98TCr 7.01TCr 6.01TCr 11TCr 7,64600Cr 12TCr 78TCr 30TCr 3,78300Cr 30TCr 29TCr 13,07900Cr |
| Net income | 1.46TCr 1.78TCr 1.56TCr 1.34TCr 2.5TCr 1,70300Cr 2.57TCr 17TCr 6.76TCr 84TCr 6.67TCr 6.53TCr 2,91300Cr | 1.64TCr 2TCr 1.75TCr 1.5TCr 2.81TCr 1,91100Cr 2.88TCr 19TCr 7.59TCr 95TCr 7.49TCr 7.33TCr 3,26900Cr |
| Net Debt | 1.07TCr 1.31TCr 1.15TCr 986.08Cr 1.85TCr 1,25500Cr 1.89TCr 13TCr 4.98TCr 62TCr 4.92TCr 4.81TCr 2,14600Cr | 396.3Cr 483.18Cr 424.57Cr 363.7Cr 680.83Cr 46TCr 697.61Cr 4.7TCr 1.84TCr 23TCr 1.81TCr 1.77TCr 79TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | CHF 323.90 | 0.00% | 532 |
| 28/26/28 | CHF 323.90 | 0.00% | 4,250 |
| 27/26/27 | CHF 323.90 | 0.00% | 6,381 |
| 24/26/24 | CHF 323.90 | 0.00% | 84,268 |
| 23/26/23 | CHF 323.90 | 0.00% | 15,316 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
Select your edition
All financial news and data tailored to specific country editions
